Figure 3From: Src activity is modulated by oxaliplatin and correlates with outcomes after hepatectomy for metastatic colorectal cancer Analysis of pSrc and pFAK expression in sequential liver metastases resected from the same patients. Patients were treated with no chemotherapy before the first resection and either with an oxaliplatin-based regimen, an irinotecan-based regimen, or no chemotherapy between resections (cohort 2, N = 15 for pSrc and N = 16 for pFAK). Each pair of points represents a single patient. Patients exposed to oxaliplatin demonstrated an increased in activated pFAK and a trend towards increased pSrc that was not observed in the patients who received no chemotherapy or an irinotecan-based regimen.Back to article page